SCHEMBL14730217

SCHEMBL14730217

CCN(C(=O)c1cnc(N2C[C@H](NC(=O)OC(C)(C)C)[C@@H](c3cc(C)ccc3F)C2)nc1)C1CCN(c2nc(C(C)C)no2)CC1

nearest known ligand 0.34

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 15/20 0.34
PDK2 Q15119 1/20 0.34
KCNH2 Q12809 2/20 0.33
NR1H2 P55055 2/20 0.33
NR1H3 Q13133 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C19 P33261 1/20 0.32
LMNA P02545 1/20 0.32
MAPT P10636 1/20 0.32
GPR183 P32249 1/20 0.32
EIF2AK4 Q9P2K8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14730173 0.95 PDK2 (0.34) PDK2NR1H2NR1H3EIF2AK4
SCHEMBL14730174 0.95 PDK2 (0.33) GPR119PDK2NR1H2NR1H3EIF2AK4
SCHEMBL14730168 0.93 GPR119 (0.36) GPR119KCNH2NR1H2NR1H3CYP3A4
SCHEMBL14730273 0.92 GPR119 (0.35) GPR119KCNH2NR1H2NR1H3CYP3A4
SCHEMBL14730327 0.92 GPR119 (0.35) GPR119PDK2KCNH2NR1H2NR1H3
SCHEMBL14730219 0.91 PDK2 (0.36) GPR119PDK2NR1H2NR1H3EIF2AK4
SCHEMBL14730259 0.91 PDK2 (0.36) GPR119PDK2KCNH2NR1H2NR1H3
SCHEMBL14730325 0.89 NTRK1 (0.33) GPR119NR1H2NR1H3MAPTEIF2AK4
SCHEMBL14730255 0.88 PDK2 (0.34) PDK2
SCHEMBL14730209 0.87 GPR119 (0.31) GPR119NR1H2NR1H3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013026587-A1 1,4 DISUBSTITUTED PYRROLIDINE - 3 - YL -AMINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS PROSIDION LIMITED (GB) 2013-02-28 WO disclosed